AMR Stakeholder Profile

Global Antibiotic Research and Development Partnership


Focus area/active in: Therapeutics

Company/Organisation type: Other

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization developing new treatments for drug-resistant infections that pose the greatest threat to health. GARDP was created by the World Health Organization (WHO) and the Drugs for Neglected Diseases initiative(DNDi) in 2016 to ensure that everyone who needs antibiotics receives effective and affordable treatment, no matter where they live. We aim to develop five new treatments by 2025 to fight drug-resistant infections, focusing on sexually transmitted infections, sepsis in newborns and infections in hospitalized adults and children. GARDP is funded by the governments of Germany, Japan, Luxembourg, Monaco, Netherlands, South Africa, Switzerland, United Kingdom, as well as Médecins Sans Frontières and private foundations.


Follow us:

Get in touch!

Jean-Pierre Paccaud
Director of Business Development and Corporate Strategy
Global Antibiotic Research and Development Partnership

Please fill out the form below to get in touch with us.

Share this page: